http://www.cnr.it/ontology/cnr/individuo/prodotto/ID38733
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. (Articolo in rivista)
- Type
- Label
- PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. (Articolo in rivista) (literal)
- Anno
- 2010-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1371/journal.pone.0013108 (literal)
- Alternative label
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Tiziana Bachetti; Daniela Di Paolo; Simona Di Lascio; Valentina Mirisola; Chiara Brignole; Marta Bellotti; Irene Caffa; Chiara Ferraris; Michele Fiore; Diego Fornasari; Roberto Chiarle; Silvia Borghini; Ulrich Pfeffer; Mirco Ponzoni; Isabella Ceccherini; Patrizia Perri (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Laboratory of Molecular Genetics, G. Gaslini Children's Hospital, Genoa, Italy
Experimental Therapy Unit, Laboratoty of Oncology, G. Gaslini Children's Hopsital, Genoa, Italy
Dept. of Pharmacology, School of Medicine, Università degli Studi di Milano, Milan, Italy
Advanced Molecular Diagnostics, National Cancer Research Institute, Genoa, Italy
Experimental Therapy Unit, Laboratoty of Oncology, G. Gaslini Children's Hopsital, Genoa, Italy
Advanced Molecular Diagnostics, National Cancer Research Institute, Genoa, Italy
Experimental Therapy Unit, Laboratoty of Oncology, G. Gaslini Children's Hospital, Genoa, Italy
Laboratory of Molecular Genetics, G. Gaslini Children's Hospital, Genoa, Italy
Laboratory of Molecular Genetics, G. Gaslini Children's Hospital, Genoa, Italy
Dept. of Pharmacology, School of Medicine, Università degli Studi di Milano, Milan, Italy - CNR, Institute of Neuroscience, Milan, Italy
Dept. Biochemical Sciences and Human Oncology, University of Turin, Turin, Italy
Laboratory of Molecular Genetics, G. Gaslini Children's Hospital, Genoa, Italy
Advanced Molecular Diagnostics, National Cancer Research Institute, Genoa, Italy
Experimental Therapy Unit, Laboratoty of Oncology, G. Gaslini Children's Hospital, Genoa, Italy
Laboratory of Molecular Genetics, G. Gaslini Children's Hospital, Genoa, Italy
Experimental Therapy Unit, Laboratoty of Oncology, G. Gaslini Children's Hospital, Genoa, Italy (literal)
- Titolo
- PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. (literal)
- Abstract
- Background: Neuroblastoma (NB) is a severe pediatric tumor originating from neural crest derivatives and accounting for
15% of childhood cancer mortality. The heterogeneous and complex genetic etiology has been confirmed with the
identification of mutations in two genes, encoding for the receptor tyrosine kinase Anaplastic Lymphoma Kinase (ALK) and
the transcription factor Paired-like Homeobox 2B (PHOX2B), in a limited proportion of NB patients. Interestingly, these two
genes are overexpressed in the great majority of primary NB samples and cell lines. These observations led us to test the
hypothesis of a regulatory or functional relationship between ALK and PHOX2B underlying NB pathogenesis.
Methodology/Principal Findings: Following this possibility, we first confirmed a striking correlation between the
transcription levels of ALK, PHOX2B and its direct target PHOX2A in a panel of NB cell lines. Then, we manipulated their
expression in NB cell lines by siRNA-mediated knock-down and forced over-expression of each gene under analysis.
Surprisingly, PHOX2B- and PHOX2A-directed siRNAs efficiently downregulated each other as well as ALK gene and,
consistently, the enhanced expression of PHOX2B in NB cells yielded an increment of ALK protein. We finally demonstrated
that PHOX2B drives ALK gene transcription by directly binding its promoter, which therefore represents a novel PHOX2B
target.
Conclusions/Significance: These findings provide a compelling explanation of the concurrent involvement of these two
genes in NB pathogenesis and are going to foster a better understanding of molecular interactions at the base of the
disease. Moreover, this work opens new perspectives for NBs refractory to conventional therapies that may benefit from the
design of novel therapeutic RNAi-based approaches for multiple gene targets. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Prodotto
- Autore CNR di
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di